EMEA-000084-PIP02-10

Key facts

Invented name
Maxalt and associated names
Active substance
Rizatriptan
Therapeutic area
Pain
Decision number
P/27/2011
PIP number
EMEA-000084-PIP02-10
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of migraine
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.
Belgium
E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number
EMEA-C-000084-PIP02-10
Compliance opinion date
14/09/2011
Compliance outcome
positive

Decision

How useful was this page?

Add your rating